INSIGHTS ON CLINICAL TRIAL PARTNERING
-
The Case For Parallel Processing In Clinical Trial Start-Up
Stop letting outdated processes stall your innovation and learn how parallel processing transforms study start-up from a series of hurdles into a synchronized sprint.
-
Increasing Efficiency And Reducing Drug Waste
Discover how streamlined clinical supply chain management helped accelerate study timelines, reduce costs, and support global treatment delivery through a strategic technology partnership.
-
Working With A Specialty Oncology CRO Versus A Large Generalist CRO
Specialty oncology CROs bridge the gap between traditional CRO operating models and the specialized needs of oncology sponsors by embedding deep oncology expertise across every function.
-
How Will The Ophthalmologist Shortage Impact Your Next Study?
With a shortage of ophthalmologists affecting patients in both ophthalmic and non-ophthalmic clinical trials, the industry is looking for new solutions to ensure trial success and efficiency.
-
Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call3/21/2025
Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.
-
Advancing Ovarian Cancer Therapies: Clinical Research Trends, Challenges, And Proven Strategies8/29/2025
Ovarian cancer remains one of the deadliest gynecologic malignancies. Successful clinical trials in this space demand deep therapeutic expertise, operational agility, and global coordination.
-
How RFI/RFP Optimization Changes The Game8/22/2025
Selecting the right vendors can determine whether a clinical trial advances smoothly or stalls under budget overruns and delays.
-
Expand Bandwidth With A Trusted Regulatory Writing Partner9/18/2025
Find out how a mid-size biotech lacking the bandwidth, expertise, and resources to independently handle its regulatory writing requirements overcame this challenge.
-
When Your Protocol Includes Ocular Endpoints4/6/2026
Standardizing ocular endpoint execution reduces participant dropout and eliminates data variability. Specialized oversight secures clinical timelines and ensures high-quality, submission-ready data.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.
-
Advancing biologics from start to finish is highly complex and full of challenges, requiring scientific strategies and implementation.
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.
-
Navigating the complex landscape of scientific and regulatory affairs is a challenge for biotech companies. That's why our team is committed to providing solutions tailored to meet these unique needs.
-
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.